T. Schilling

440 total citations
9 papers, 351 citations indexed

About

T. Schilling is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, T. Schilling has authored 9 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Molecular Biology. Recurrent topics in T. Schilling's work include Cancer Treatment and Pharmacology (5 papers), Cancer therapeutics and mechanisms (3 papers) and Brain Metastases and Treatment (2 papers). T. Schilling is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Cancer therapeutics and mechanisms (3 papers) and Brain Metastases and Treatment (2 papers). T. Schilling collaborates with scholars based in Germany, Italy and France. T. Schilling's co-authors include Axel‐R. Hanauske, Manfred Heim, G Niebch, Hermann Dietzfelbinger, Jürgen Pache, Claus Schmitt, Josef Dirschinger, Adnan Kastrati, Franz–Josef Neumann and Julinda Mehilli and has published in prestigious journals such as Circulation, European Journal of Cancer and Transplantation.

In The Last Decade

T. Schilling

9 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
T. Schilling Germany	7	134	121	96	89	63	9	351
Won Joon Choi South Korea	13	122 0.9×	77 0.6×	213 2.2×	43 0.5×	29 0.5×	34	678
Haiping Wang China	11	60 0.4×	106 0.9×	46 0.5×	183 2.1×	8 0.1×	33	519
Takaaki Yamamoto Japan	11	38 0.3×	55 0.5×	57 0.6×	44 0.5×	17 0.3×	44	382
Jae Hak Lee South Korea	11	40 0.3×	44 0.4×	109 1.1×	32 0.4×	35 0.6×	46	386
Yuki Izumi Japan	12	35 0.3×	99 0.8×	98 1.0×	35 0.4×	116 1.8×	41	518
Mervyn Jones United Kingdom	9	30 0.2×	303 2.5×	165 1.7×	33 0.4×	11 0.2×	10	461
John Yu-Chih Chang New Zealand	8	122 0.9×	76 0.6×	75 0.8×	7 0.1×	26 0.4×	9	315
F. Elferink Netherlands	9	81 0.6×	161 1.3×	32 0.3×	36 0.4×	8 0.1×	14	369
Stephanie N. Johnson United States	8	49 0.4×	29 0.2×	149 1.6×	42 0.5×	101 1.6×	14	402

Countries citing papers authored by T. Schilling

Since Specialization

Citations

This map shows the geographic impact of T. Schilling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Schilling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Schilling more than expected).

Fields of papers citing papers by T. Schilling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Schilling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Schilling. The network helps show where T. Schilling may publish in the future.

Co-authorship network of co-authors of T. Schilling

This figure shows the co-authorship network connecting the top 25 collaborators of T. Schilling. A scholar is included among the top collaborators of T. Schilling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Schilling. T. Schilling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Kastrati, Adnan, Albert Schömig, Josef Dirschinger, et al.. (2000). Increased Risk of Restenosis After Placement of Gold-Coated Stents. Circulation. 101(21). 2478–2483. 150 indexed citations

Schilling, T., Bernhard Heinrich, Reinhardt J. Kau, et al.. (1997). Paclitaxel Administered over 3 h Followed by Cisplatin in Patients with Advanced Head and Neck Squamous Cell Carcinoma: A Clinical Phase I Study. Oncology. 54(2). 89–95. 15 indexed citations

Mross, K., Andreas Hüttmann, Kenneth D. Herbst, et al.. (1996). Pharmacokinetics and pharmacodynamics of the new podophyllotoxin derivative NK 611 A study by the AIO groups PHASE-I and APOH. Cancer Chemotherapy and Pharmacology. 38(3). 217–224. 16 indexed citations

Schilling, T., Heiner Fiebig, B. R. Winterhalter, et al.. (1996). Clinical phase I and pharmacokinetic trial of vinorelbine administered as single intravenous bolus every 21 days in cancer patients. Investigational New Drugs. 14(4). 371–378. 23 indexed citations

Schilling, T., et al.. (1996). Clinical and pharmacokinetic phase I trial of oral dimethylaminoetoposide (NK611) administered for 21 days every 35 days. Investigational New Drugs. 14(4). 379–386. 8 indexed citations

Schilling, T., et al.. (1995). Clinical phase I and pharmacokinetic trial of the new titanium complex budotitane. Investigational New Drugs. 13(4). 327–332. 124 indexed citations

Schilling, T., et al.. (1995). 111 Phase I clinical and pharmacokinetic trial of the podophyllotoxin derivative NK 611 using an oral daily administration schedule. European Journal of Cancer. 31. S27–S27. 1 indexed citations

Schilling, T., et al.. (1995). Clinical phase I study of paclitaxel followed by cisplatin in advanced head and neck squamous cell carcinoma.. PubMed. 22(6 Suppl 14). 35–9. 11 indexed citations

Heidecke, Claus-Dieter, Robert Brauer, Jan Schneider-Eicke, et al.. (1990). DIRECT EVIDENCE OF A FUNCTIONAL SEPARATION OF ALLOREACTIVE T LYMPHOCYTES FROM BYSTANDER CELLS INFILTRATING RAT ALLOGRAFTS. Transplantation. 50(1). 101–105. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact